GlassScriptPhysician profile
Jacquelyn A Dunahoe
NPI 1245694645
$13,002.87
in general payments reported to CMS, 2019-2025
7 companies · $6,394 in 2025
The $6,394 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $376 · 2022: $669 · 2023: $747 · 2024: $4,816 · 2025: $6,394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,821 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,750 · Food and Beverage: $1,887 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,820.90 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,750.00 |
| Food and Beverage | $1,886.78 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $8,882.79 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $2,358.90 | 2021-2025 | Oxford, Avenir |
| Stryker Corporation | $1,079.33 | 2021-2024 | Variax, Mako |
| Depuy Synthes Sales INC. | $292.91 | 2023 | Na |
| Elite Orthopedics, LLC | $211.76 | 2022-2023 | |
| Smith+Nephew, INC. | $160.98 | 2022-2023 | Evos |
| Medical Device Business Services, INC. | $16.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Dunahoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.